KCNK6 | Potassium channel, subfamily K, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNK7 | Potassium channel, subfamily K, member 7 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNN1 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNN3 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNQ3 | Potassium voltage-gated channel, KQT-like subfamily, member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNQ4 | Potassium voltage-gated channel, KQT-like subfamily, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNV1 | Potassium channel, subfamily V, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNV2 | Potassium channel, subfamily V, member 2 | Disease related genes Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
KIAA0195 | KIAA0195 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
LAPTM5 | Lysosomal protein transmembrane 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
LMF1 | Lipase maturation factor 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LPPR2 | Lipid phosphate phosphatase-related protein type 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LPPR3 | Lipid phosphate phosphatase-related protein type 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MBOAT7 | Membrane bound O-acyltransferase domain containing 7 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MFSD12 | Major facilitator superfamily domain containing 12 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MFSD6 | Major facilitator superfamily domain containing 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MMD2 | Monocyte to macrophage differentiation-associated 2 | Predicted membrane proteins
| | | | | Group enriched |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MT-ND6 | Mitochondrially encoded NADH dehydrogenase 6 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MYADM | Myeloid-associated differentiation marker | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NOX4 | NADPH oxidase 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NPC1 | Niemann-Pick disease, type C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NRM | Nurim (nuclear envelope membrane protein) | Predicted membrane proteins
| | | | | Mixed |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY6 | Pyrimidinergic receptor P2Y, G-protein coupled, 6 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PCNXL2 | Pecanex-like 2 (Drosophila) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
PGAP2 | Post-GPI attachment to proteins 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PGAP3 | Post-GPI attachment to proteins 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PHTF2 | Putative homeodomain transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PIGF | Phosphatidylinositol glycan anchor biosynthesis, class F | Predicted membrane proteins
| | | | | Expressed in all |
PIGO | Phosphatidylinositol glycan anchor biosynthesis, class O | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PIGU | Phosphatidylinositol glycan anchor biosynthesis, class U | Predicted membrane proteins
| | | | | Expressed in all |
POMT1 | Protein-O-mannosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PPAPDC1A | Phosphatidic acid phosphatase type 2 domain containing 1A | Enzymes Predicted membrane proteins
| | | | | Group enriched |
PPAPDC1B | Phosphatidic acid phosphatase type 2 domain containing 1B | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PQLC1 | PQ loop repeat containing 1 | Predicted membrane proteins
| | | | | Expressed in all |
PQLC2 | PQ loop repeat containing 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |